NHTC Reports 76% Increase in First Quarter Revenues to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NHTC Reports 76% Increase in First Quarter Revenues to $40.7 Million; Net Income Increased 119% to $6.7 Million

DALLAS, May 5, 2015 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (Nasdaq: NHTC ), a leading direct selling company that markets premium quality personal care, wellness and "quality of life" products under the NHT Global brand , today announced financial results for the quarter ended March 31, 2015.

First Quarter Highlights

  • Total revenues increased 76% to $40.7 million, compared to $23.2 million in the first quarter last year.
    • Revenue from Hong Kong operations, which represents 92% of total revenue, increased $16.9 million, or 83% over last year
    • Revenue outside of Hong Kong increased $619,000, or 23% over last year
  • Operating income increased 122% to $6.9 million, compared to $3.1 million in the first quarter last year.
  • Net income was $6.7 million, or $0.54 per diluted share, compared to $3.1 million, or $0.26 per diluted share, in the first quarter last year.
  • Total number of active distributors increased 14% to 62,010 at March 31, 2015 compared to year end 2014.

"We have delivered a great start for the year," commented Chris Sharng, President of Natural Health Trends Corp. "Our success in Greater China continues, attributable to the effectiveness of our leadership development, products, training and marketing programs."

"We are also excited to see significant increases in North America, albeit from a small base," continued Mr. Sharng. "Along with our initiatives in Southeast Asia, we may develop more sources for growth."

Balance Sheet

At March 31, 2015, cash and cash equivalents totaled $59.9 million, compared to $44.8 million as of December 31, 2014. At March 31, 2015, the Company had working capital of $30.9 million, an increase of $5.7 million compared to December 31, 2014, resulting in a current ratio of 1.88 to 1.

Dividend and Share Repurchase

Yesterday, the Board of Directors declared a dividend of $0.03 per share, a 50% increase over the prior quarter dividend, on outstanding common stock payable in cash on May 29, 2015 to stockholders of record on May 19, 2015.

Also yesterday, the Board of Directors approved a special stock repurchase of up to $5 million of the Company's outstanding shares of common stock. Such repurchases are expected to begin soon and be made in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934 (the "Exchange Act"). For all or a portion of the authorized repurchase amount, the Company may enter into a plan that is compliant with Rule 10b5-1 of the Exchange Act that is designed to facilitate these purchases. The repurchase program does not require the Company to acquire a specific number of shares, and may be suspended from time to time or discontinued. The share repurchases will be funded from available working capital.

Shareholder Conference Call

Management will conduct a conference call to discuss its first quarter financial results. Details of the call are as follows:

A replay will be available from 1 p.m. ET on May 5, 2015 through 11:59 p.m. ET on May 12, 2015 by dialing 1-877-870-5176 (domestic) and 1-858-384-5517 (international) and referencing replay pin number 7712921.

About Natural Health Trends Corp.

Natural Health Trends Corp. is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, North America, and Europe. The company markets premium quality personal care, wellness and "quality of life" products under the NHT Global brand. Additional information can be found on the company's website, www.naturalhealthtrendscorp.com .

Forward Looking Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause our actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption "Risk Factors" in our Annual Report on Form 10-K filed on March 6, 2015, with the Securities and Exchange Commission. We assume no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

-- Tables follow --

NATURAL HEALTH TRENDS CORP. CONSOLIDATED BALANCE SHEETS (In Thousands, Except Share Data)
     
  December 31, 2014 March 31, 2015
    (Unaudited)
ASSETS    
Current assets:    
Cash and cash equivalents $44,816 $59,866
Accounts receivable 107 178
Inventories, net 3,760 4,859
Other current assets 930 1,179
Total current assets 49,613 66,082
Property and equipment, net 476 699
Goodwill 1,764 1,764
Restricted cash 315 312
Other assets 372 591
Total assets $52,540 $69,448
     
LIABILITIES AND STOCKHOLDERS' EQUITY    
     
Current liabilities:    
Accounts payable $2,232 $2,543
Income taxes payable 268 208
Accrued distributor commissions 8,853 7,430
Other accrued expenses 6,743 7,874
Deferred revenue 2,687 10,371
Deferred tax liability 65 65
Amounts held in distributor eWallets 2,064 4,962
Other current liabilities 1,513 1,717
Total current liabilities 24,425 35,170
Long-term incentive 1,665 1,603
Total liabilities 26,090 36,773
Commitments and contingencies    
Stockholders' equity:    
Preferred stock – –
Common stock 13 13
Additional paid-in capital 85,750 85,608
Accumulated deficit (54,799) (48,359)
Accumulated other comprehensive income:    
 Foreign currency translation adjustments 62 199
Treasury stock, at cost (4,576) (4,786)
Total stockholders' equity 26,450 32,675
Total liabilities and stockholders' equity $52,540 $69,448
 
 
NATURAL HEALTH TRENDS CORP.   CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In Thousands, Except Per Share Data)
     
  Three Months Ended March 31,
  2014 2015
     
Net sales $23,162 $40,709
Cost of sales 5,252 8,930
Gross profit 17,910 31,779
Operating expenses:    
Distributor commissions 10,423 18,397
Selling, general and administrative expenses 4,347 6,423
Depreciation and amortization 21 41
Total operating expenses 14,791 24,861
Income from operations 3,119 6,918
Other expense, net (9) (109)
Income before income taxes 3,110 6,809
Income tax provision 39 71
Net income 3,071 6,738
Preferred stock dividends (4) –
Net income available to common stockholders $3,067 6,738
     
Income per common share:    
Basic $0.27 $0.54
Diluted $0.26 $0.54
     
Weighted-average number of common shares outstanding:    
Basic 11,361 12,453
Diluted 11,673 12,548
     
Cash dividends declared per share:    
Common $0.005 $0.02
Series A preferred stock $0.815 $–
 
 
NATURAL HEALTH TRENDS CORP.  CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In Thousands)
     
  Three Months Ended March 31,
  2014 2015
     
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $3,071 $6,738
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 21 41
Stock-based compensation 25 15
Changes in assets and liabilities:    
Accounts receivable (39) (69)
Inventories, net (1,527) (1,101)
Other current assets (1,105) (259)
Other assets – (221)
Accounts payable 1,381 352
Income taxes payable 28 (59)
Accrued distributor commissions 21 (1,419)
Other accrued expenses 1,040 1,808
Deferred revenue 5,320 7,683
Amounts held in distributor eWallets – 2,897
Other current liabilities 47 212
Long-term incentive – (62)
Net cash provided by operating activities 8,283 16,556
     
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment, net (63) (266)
Net cash used in investing activities (63) (266)
     
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from exercise of warrants 598 –
Repurchase of common stock (24) (1,082)
Dividends paid – (250)
 Net cash provided by (used in) financing activities  574 (1,332)
     
Effect of exchange rates on cash and cash equivalents (10) 92
Net increase in cash and cash equivalents 8,784 15,050
CASH AND CASH EQUIVALENTS, beginning of period 14,550 44,816
CASH AND CASH EQUIVALENTS, end of period $23,334 $59,866
     

Company Contact Scott Davidson Chief Financial Officer Natural Health Trends Corp. Tel: 972-241-4080 Investor Contact Brett Maas Managing Partner Hayden IR Tel: 646-536-7331

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 509

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 537

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 0

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 523

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 441

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 349

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 400

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Thames Ventures VCT 1 PLC Reports Unaudited NAV for 2024

Updated Category News Views 81

Thames Ventures VCT 1 PLC Releases Unaudited NAV for 2024 Thames Ventures VCT 1 PLC has provided important updates about its financial status through its unaudited net asset value (NAV). As of June 30, 2024, the NAV stands at 45.9p per share. This announcement is significant for both the company and its investors, as understanding the NAV is essential for evaluating the...

Continue Reading
Gap Inc Achieves Impressive Growth and Market Expansion

Updated Category News Views 362

Gap Inc Reports Promising Financial Results Shares of Gap Inc (GAP) saw a significant uptick in early trading on Friday following the announcement of their latest quarterly results. This positive financial report highlighted a stronger performance than expected, showcasing the company's effective strategies and management efforts. Analysts' Positive Outlook on Gap In the...

Continue Reading
The Town Lake Company's Bold New Industrial Project Launch

Updated Category News Views 226

The Town Lake Company Initiates New Industrial Development Benchmark Business Parks, a division of The Town Lake Company, has proudly initiated construction on its latest small-bay industrial project. This significant development is located at 1433 Chris Lane and will encompass an impressive 84,200 square feet of innovative tilt-wall flex industrial space. The project is...

Continue Reading
Investors Unite in Class Action Against Everus Construction Group

Updated Category News Views 330

Opportunity for Investors in Everus Construction Group, Inc. In recent developments, investors of Everus Construction Group, Inc. (NYSE: ECG) have found themselves in the midst of a class action lawsuit that has drawn considerable attention. This lawsuit targets purchases made by investors during a specified period, raising important questions about the company's...

Continue Reading
Lam Research Board Approves Quarterly Dividend Announcement

Updated Category News Views 120

Lam Research Corporation Declares New Dividend Lam Research Corporation (Nasdaq: LRCX) has recently made an important announcement regarding its financial strategy. In their latest meeting, the company's Board of Directors approved a quarterly dividend of $0.23 per share for all common stockholders. This decision reflects Lam Research's commitment to providing value to...

Continue Reading